Overview

The Sequencing and Genomic Technologies Shared Resource is a basic research oriented core facility affiliated with the Duke Cancer Institute (DCI). This core facilitu has a track record more than a decade-long of providing constantly updated, state-of-the-art genomic services. The Sequencing and Genomic Technologies core facility offers the full range of genomic technologies, making it much simpler for researchers to find the right service for their needs. 

Associate director Devi Swain Lenz is available is available for project consultations.

DNA Sequencing          RNA Sequencing         

Nucleic Acid Extraction           Single Cell

Data Delivery: We will continue to upload your data to SFTP to quickly deliver your data. To help facilitate data delivery, we ask you to download your data as soon as possible. If you experience any difficulties, please contact sequencing@duke.edu. We appreciate your business!

COVID-19

The COVID-19 pandemic is generating various and dynamic supply chain issues from lab consumables to machine replacement parts. Consequently, the turnaround time for some of our sequencing services may be impacted. We are doing our best to secure necessary supplies, and we thank you for your patience!

Location

Duke Center for Genomic and Computational Biology
Duke University
Chesterfield Bldg. 
701 W. Main Street
Suite 320
Durham NC 27701

Start DUGSIM

Average Time in Queue

  Client-Submitted Library Core-Created Libraries
MiSeq 2 weeks 3-4 weeks
NextSeq 10 days 3-4 weeks
NovaSeq 6000 full flow cells 10 days 3-4 weeks
NovaSeq 6000 by the lane Dependent on how quickly a flow cell can be filled Dependent on how quickly a flow cell can be filled

PUBLICATION ACKNOWLEDGEMENT

For all publications that include data generated in the Sequencing and Genomic Technologies Shared Resource, we kindly request that you acknowledge this support:

We thank the Duke University School of Medicine for the use of the Sequencing and Genomic Technologies Shared Resource, which provided _________ service.